Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
Gardasil9 Vaccine for Human Papillomavirus
Recruiting1 awardPhase < 1
Boston, Massachusetts
This trial will explore whether a two-dose regimen of the 9-valent HPV vaccine is effective in providing immunity against the virus. The trial will last for four years, with participants receiving the vaccine doses at months 0 and 12.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.